ArticleCancers2022

The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.

Josée M Zijlstra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.